Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|November 28, 2025
Adenovirus Types in US Children Hospitalized or Seen in the Emergency Department With Acute Respiratory Illness, 2016-2019Tess Stopczynski, Varvara Probst, Adam Gailani, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2025
Adenovirus Species in U.S. Children With Acute Respiratory Illness, 2016-2019Varvara Probst, Tess Stopczynski, Justin Z Amarin, et al.
JAMA Pediatrics|December 9, 2024
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024Heidi L Moline, Ariana P Toepfer, Ayzsa Tannis, et al.
MMWR. Morbidity and Mortality Weekly Report|August 12, 2021
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021Heidi L Moline, Michael Whitaker, Li Deng, et al.
JAMA Internal Medicine|September 8, 2022
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022Fiona P Havers, Huong Pham, Christopher A Taylor, et al.
Lancet Regional Health. Americas|October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysisAmanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report|March 12, 2026
Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026Patrick Maloney, Emily L Reeves, Kristina Wielgosz, et al.
MMWR. Morbidity and Mortality Weekly Report|May 8, 2025
Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025Monica E Patton, Heidi L Moline, Michael Whitaker, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United StatesAaron M Frutos, Ashley M Price, Elizabeth Harker, et al.
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025Aaron M Frutos, Seana Cleary, Emily L Reeves, et al.
Pageof 5